If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Luca Baldini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 37 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

Systemic Mastocytosis
Cell Lineage
Hematologic Neoplasms
Mast-Cell Leukemia
Leukemia, Myelomonocytic, Chronic
Staphylococcal Protein A
Immunoglobulin M
Lymphoma
Waldenstrom Macroglobulinemia
Mutation

Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach

Iurlo, A., Elli, E. M., Palandri, F., Cattaneo, D., Bossi, A., Cortinovis, I., Bucelli, C., Orofino, N., Brioschi, F., Auteri, G., Bianchi, P., Fabris, S., Isimbaldi, G., Sabattini, E., Baldini, L. & Gianelli, U., Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Primary Myelofibrosis
Mutation
Practice Management
Multicenter Studies
Survival

Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

Loglio, A., Viganò, M., Grossi, G., Labanca, S., Goldaniga, M., Pompa, A., Farina, L., Rumi, M., Corradini, P., Facchetti, F., Lunghi, G., Baldini, L. & Lampertico, P., 2019, In : Digestive and Liver Disease. 51, 3, p. 419-424

Research output: Contribution to journalArticle

Hepatitis B Core Antigens
Hepatitis B Antibodies
Lamivudine
Hepatitis B virus
Non-Hodgkin's Lymphoma

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network

on behalf of the “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup), Jan 1 2019, In : Hematological Oncology.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Virus Diseases
Hepacivirus
Multicenter Studies
Lymphoma